The term \u201cAI-driven drug discovery\u201d has become ubiquitous.
Across pharmaceutical companies, startups, investors, and the media, it is spoken as if the future has already arrived.<\/p>\n\n\n\n
Yet, among those who have spent years in drug discovery, a quiet sense of unease often remains.
Is AI truly transforming drug discovery?
Or have expectations begun to outpace reality?<\/p>\n\n\n\n
This article is not written to dismiss AI in drug discovery.
Rather, it aims to revisit the fundamental nature of drug discovery itself, as a necessary step toward understanding what AI can\u2014and cannot\u2014do.<\/p>\n\n\n\n
The phrase \u201cAI drug discovery\u201d carries an unusually strong appeal.
It combines artificial intelligence, medicine, and innovation into a single, compelling narrative.<\/p>\n\n\n\n
This is not the result of bad intent.
The term is convenient for startups, reassuring for investors, and attractive for corporate storytelling.
As a result, the language often travels faster than the underlying definitions of success or progress.<\/p>\n\n\n\n
This phenomenon is not unique to drug discovery. It is a familiar pattern in the early phases of technological change.<\/p>\n\n\n\n
Generative AI excels at identifying patterns across vast datasets and recombining them into coherent outputs.
This capability allows it to generate responses that appear highly convincing.<\/p>\n\n\n\n
In drug discovery, however, plausibility can be misleading.
Breakthroughs rarely emerge from average solutions. They arise from exceptions.<\/p>\n\n\n\n
While AI is effective at producing statistically reasonable answers, identifying meaningful outliers remains largely a human responsibility.<\/p>\n\n\n\n
Data abundance does not equal data quality.
In drug discovery, datasets are heavily biased toward successful outcomes.<\/p>\n\n\n\n
Crucial context\u2014why an experiment was designed a certain way, why it failed, or why results were discarded\u2014is rarely captured.
AI can learn from structured outcomes, but not from the reasoning that led to critical decisions.<\/p>\n\n\n\n
A high-quality tuna cannot be selected by numbers alone.
Price, origin, and volume offer clues, but true judgment depends on texture, color, fat distribution\u2014and subtle discomfort.<\/p>\n\n\n\n
Drug discovery is remarkably similar.
Physicochemical properties and activity data matter, but experienced practitioners also sense when data feels \u201ctoo clean\u201d or unreliable.<\/p>\n\n\n\n
AI processes numbers.
It does not feel unease.<\/p>\n\n\n\n
Drug discovery is a sequence of decisions.
Proceed or stop. Invest further or walk away.<\/p>\n\n\n\n
These decisions involve science, time, capital, organizational constraints, and regulation.
Integrating these dimensions into a single judgment remains beyond current AI capabilities.<\/p>\n\n\n\n
None of this diminishes the value of AI.
AI expands search spaces, accelerates hypothesis generation, and supports human reasoning.<\/p>\n\n\n\n
The challenge lies in clarifying what we expect AI to do\u2014and what we should not.<\/p>\n\n\n\n
AI is not the reason drug discovery is difficult.
Drug discovery has always been a low-reproducibility, experience-driven endeavor.<\/p>\n\n\n\n
In many ways, AI has simply exposed this reality more clearly.<\/p>\n\n\n\n
AI drug discovery is not an answer.
It is a question\u2014about how deeply we understand drug discovery itself.<\/p>\n\n\n\n
Just as the ability to select a great tuna requires years of experience, so too does the ability to judge promising science.
Algorithms alone cannot replace this craft.<\/p>\n\n\n\n
If we can begin by having a deeper conversation about what drug discovery truly entails, then AI may finally find its rightful place within it.<\/p>\n","protected":false},"excerpt":{"rendered":"
0. Introduction: Why Talk About AI and Drug Discovery Now? The term \u201cAI-driven drug discovery\u201d has become ubiquitous.Across pharmaceutical companies, startups, investors, and the media, it is spoken as if the future has already arrived. Yet, among those who have spent years in drug discovery, a quiet sense of unease often remains.Is AI truly transforming […]<\/p>\n","protected":false},"author":1,"featured_media":818,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"swell_btn_cv_data":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-816","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article"],"yoast_head":"\n